Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.
暂无分享,去创建一个
Dai Fukumura | Rakesh K Jain | R. Jain | L. Munn | D. Fukumura | N. Forbes | Lance L Munn | Neil S Forbes
[1] John Mao,et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Jain,et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.
[3] R. Jain. The next frontier of molecular medicine: Delivery of therapeutics , 1998, Nature Medicine.
[4] D. Bermudes,et al. Live bacteria as anticancer agents and tumor-selective protein delivery vectors. , 2002, Current opinion in drug discovery & development.
[5] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.
[6] X. Luo,et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. , 2000, The Journal of infectious diseases.
[7] R. Jain,et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. , 1992, Cancer research.
[8] M. Belcourt,et al. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. , 2002, Human gene therapy.
[9] R. Wilson,et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2 , 2001, Nature.
[10] R. B. Campbell,et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy , 2001, Nature Medicine.
[11] P. Lambin,et al. Clostridium spores for tumor-specific drug delivery. , 2002, Anti-cancer drugs.
[12] Brian Seed,et al. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation , 2003, Nature Medicine.
[13] R. Jain,et al. Can engineered bacteria help control cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. Stocker,et al. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. , 1996, Vaccine.
[15] K. Kinzler,et al. Combination bacteriolytic therapy for the treatment of experimental tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] Samuel I. Miller,et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo , 1999, Nature Biotechnology.
[17] Kim Rutherford,et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18 , 2001, Nature.
[18] P. Lambin,et al. Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters. , 2001, Anticancer research.
[19] AJ Giaccia,et al. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis , 2002, Gene Therapy.